NFKB1 and Insulin resistance: Overall, most anti-diabetic therapeutics demonstrate anti-inflammatory effects (Figure 3), either indirectly by improving insulin resistance or directly by down-regulating proinflammatory pathways such as those involving nuclear factor κB (NF-κB).